Black Diamond Therapeutics, Inc. (BDTX)

NASDAQ: BDTX · IEX Real-Time Price · USD
2.47
+0.03 (1.23%)
At close: Jun 29, 2022 4:00 PM
2.55
+0.08 (3.24%)
After-hours: Jun 29, 2022 6:50 PM EDT

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year 20212020201920182017
Selling, General & Admin
30.0421.367.581.950.67
Research & Development
96.8348.2121.756.953.45
Operating Expenses
126.8769.5729.338.94.12
Operating Income
-126.87-69.57-29.33-8.9-4.12
Interest Expense / Income
00000.07
Other Expense / Income
-1.28-2.325.930.030.42
Pretax Income
-125.6-67.25-35.26-8.93-4.6
Net Income
-125.6-67.25-35.26-8.93-4.6
Net Income Common
-125.6-67.25-35.26-8.93-4.6
Shares Outstanding (Basic)
3633222
Shares Outstanding (Diluted)
3633222
Shares Change
9.97%1485.31%2.83%4.91%-
EPS (Basic)
-3.47-2.05-16.99-4.42-2.39
EPS (Diluted)
-3.47-2.05-16.99-4.42-2.39
Free Cash Flow Per Share
-2.84-1.59-11.90-4.23-1.26
EBITDA
-125.39-67.2-35.21-8.89-4.51
Depreciation & Amortization
0.210.050.050.040.02
EBIT
-125.6-67.25-35.26-8.93-4.54
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).